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Abstract
In communicating chronic risks, there is increasing use of a metaphor that can be termed ‘effective-age’: the age of
a ‘healthy’ person who has the same risk profile as the individual in question. Popular measures include ‘real-age’,
‘heart-age’, ‘lung-age’ and so on.
Here we formally define this concept, and illustrate its use in a variety of areas. We explore conditions under which
the years lost or gained that are associated with exposure to risk factors depends neither on current chronological
age, nor the period over which the risk is defined. These conditions generally hold for all-cause adult mortality,
which enables a simple and vivid translation from hazard-ratios to years lost or gained off chronological age. Finally
we consider the attractiveness and impact of this concept.
Under reasonable assumptions, the risks associated with specific behaviours can be expressed in terms of years
gained or lost off your effective age. The idea of effective age appears a useful and attractive metaphor to vividly
communicate risks to individuals.
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Background
Communicating statistical risk information plays a vital
part in the process of shared-care and informed health
choices, whether using patient decision-aids or in more
informal dialogue with health professionals. There has
been recent guidance on communication tools for the
risks of treatment outcomes [1], but these measures are
concerned with the chances of events occurring within a
fixed time period, say death following surgery.
Communicating chronic risks, associated with an in-
creased chance event of an adverse event throughout the
whole life-course, is more complex. The standard measure
used by epidemiologists is the ‘hazard ratio’, which is the
increased instantaneous risk associated with exposure to
the risk factor, but this is a ‘relative risk’ measure that is
known to produce an exaggerated impression [1].
An increasingly popular alternative is to assess what
we shall call the ‘effective age’ of either a whole person
or a particular organ. Many different terms are used for
this metaphor: for example, websites will tell you your
‘real age’ [2] your ‘health age’ [3], ‘vitality age’ [4], or ‘bio-
logical age’ [5] (although the basis for these calculations
is unclear), while your ‘Ubble Age’ [6] is that of people
of the same gender whose mean risk of dying in the next
5 years matches your risk. You can also, if you wish, ob-
tain your ‘heart age’ [7], ‘lung age’ [8], or ‘brain age’ [9].
In each case an individual enters various characteris-
tics of their health and habits, and their effective age is
calculated. The idea is to allow people to compare their
effective age with their chronological age, and hence
provide a vivid idea of their state of health. One aim is
to motivate them to reduce an increased effective age by
either changing their behaviour or taking medical
interventions.
Here we define precisely what is meant by effective
age, give examples of its use as a communication tool,
and relate it to previous work on ‘risk advancement pe-
riods’. The difference between an individual’s effective
and chronological age is an attractive measure of either
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premature ageing or continued youthfulness, and we de-
rive conditions under which this difference is independ-
ent of both chronological age and the horizon over
which the risk is measured. Finally, we summarise ex-
perience of the impact of this metaphor, and consider its
future use.
Main text
The meaning of ‘effective age’
Given a specified measure of ‘risk’, your effective age can
be defined as the age of a typical ‘healthy’ person who
matches your risk profile. So if your chronological age is
50, but your effective age is 60, this means that you are
in the same risk category as a 60-year old who has
‘healthy’ risk factors, or at least the ones that are poten-
tially modifiable.
The generic idea is shown in Fig. 1: a reference trajec-
tory of a typical ‘healthy’ person is calculated, and then a
subject’s actual risk level is mapped across to the find
the age of a ‘healthy’ person with the matching level.
The same idea can be used for specific organs of the
body. In particular, many cardio-vascular risk calculators
will provide your ‘heart age’ or a ‘vascular age’ [10], and
examples use a variety of risk measures:
 The UK National Health Service Heart Age [7],
based on the JBS3 calculator [11]: this is the age of a
someone of the same gender who has healthy risk
factors and a matching annual risk of heart attack or
stroke.
 The UK Heart Age calculator [12] and QRISK2 [13]
calculate the age of a person with healthy risk factors
and the same 10-year cardiovascular risk (assuming
no deaths from other causes during this period).
 The New Zealand ‘Know your Numbers’ [14]
program provides the age of someone with matching
5-year cardiovascular risk (again assuming no deaths
from other causes during this period).
The concept of lung-age was developed over 30 years
ago [15]: using updated equations, calculators [8] derive
the age for which your lung function results would be
expected in a typical person of your age and height.
There are two crucial decisions in defining an effective
age. The first is the specification of a ‘healthy’ person: for
example, the Heart Age calculator on NHS Choices [7]
uses a person of the same gender and ethnicity, and who
is a non-smoker with no clinical conditions, a BMI of 26,
systolic blood pressure 120, and LDL/HDL cholesterol ra-
tio of 3.5. This choice of a ‘standard’ individual can have a
major impact on the properties of the procedure. The
‘Ubble age’ calculator [6], based on nearly 500,000 UK Bio-
bank participants [16], uses the population 5-year all-
cause mortality as the reference level, but most of this risk
comes from the few individuals who are already sick, and
so greatly overestimates the risk of the vast majority of the
population: it is one of those anomalous situations where
nearly everyone is less than average. The consequence is
that almost everyone’s Ubble age is considerably less than
their chronological age – often around 10 years. In this
case a better comparator may have been the 5-year all-
cause mortality of a healthy population, or the median ra-
ther than mean risk.
The second decision is the choice of risk measure, and
in particular whether it represents an instantaneous risk
or ‘hazard’, or is defined as the chance of an adverse
event of a fixed horizon, say 10 years. There is a strong
relation to the work of Brenner and colleagues [17], who
consider the difference between a person’s effective age
(although they do not use this term) and their chrono-
logical age as advancing the time that they may suffer an
adverse event, which they call an ‘advancement period’.
If the risk is an ‘instantaneous’ measure, they term this a
‘rate advancement period’, and if it is a risk over a fixed
horizon, say the chance of developing cancer in the next
10 years, they term this a ‘risk advancement period’.
For example, Liese and colleagues [18] used Rate Ad-
vancement Periods (RAPs) to communicate increased
heart-attack risk from hypertension (RAP = 8 years) and
smoking (RAP =11 years): the latter says that, compared
with never/former smokers, smokers are expected to ad-
vance their risk of myocardial infarction approximately
11 years.
When can we ignore your current age and the risk
horizon?
The difference between effective and chronological age
could be called the ‘years lost/gained’ - for example if
you are 50 years old, but your effective age is 60, you
have ‘lost’ 10 years. It would be attractive if this differ-
ence did not depend on chronological age, so individuals
could be told how specific behaviours added or sub-
tracted so many years from their effective age: for
Fig. 1 Schematic representation of the meaning of your ‘effective’
age with respect to a particular risk measure
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example, that smoking 20 a day added 8 years to your
effective age, however old you are at the moment.
Suppose we are concerned with a risk measure R, a
chronological age t, and an exposure x, coded 1 if ex-
posed, 0 otherwise. Then Brenner et al. [17] show that if
there is an increasing function g such that
g Rð Þ ¼ aþ bxþ ct;
then an individual with the risk factor (x = 1) and
chronological age t0 will have the same risk as someone
without the risk factor (x = 0) and age t1 = t0 + b/c, since
g Rð Þ ¼ aþ bþ ct0 ¼ aþ c t0 þ b=cð Þ ð1Þ
Thus under these conditions the ‘risk advancement
period’ t1 − t0 = b/c does not depend on the chrono-
logical age t0.
We’ve also seen that, for example, different versions of
‘heart-age’ can depend on your risk of a heart attack this
year, over the next 5 years, or the next 10 years. It would
be desirable if this risk ‘horizon’ were irrelevant.
It turns out that there are reasonable assumptions
under which both your years lost/gained do not depend
on your current age, and your effective age does not
depend on the risk horizon. In the Additional file 1 we
prove that both these attractive properties hold given
the following two conditions:
Condition 1. There are ‘proportional hazards’: i.e. risk
factors act on the baseline trajectory by increasing the
annual risk by a percentage that does not depend on
current age.
Condition 2. The instantaneous risk (hazard) of a
healthy person increases exponentially with age, i.e.
each year increases the risk by a fixed percentage.
These conditions are equivalent to assuming, in Eq.
(1), that h is the instantaneous risk of an event, and g is
the logarithmic function, so that log(h) = a + bx + ct, or
h ¼ eaþbxþct ð2Þ
Thus eb and ec are the hazard ratios associated with a
unit increase in the risk factor, and a year of ageing,
respectively.
Fortunately these two conditions are reasonably plaus-
ible in a wide range of situations. The first condition is
the standard assumption in the Cox regression model
used widely in epidemiological studies, while we now
show that the second condition of an exponentially-
increasing hazard can be assumed to hold over a wide
age-range, at least for all-cause mortality.
Figure 2 shows the annual risk (or hazard) of death for
an average person during each year of age in England
and Wales between 2010 and 2012 [19] – this is trad-
itionally known as the ‘force of mortality’.
We note the steep decline once one has survived early
childhood, to a minimum of less than 1 in 10,000 at
around 10 years old (in spite of the anxieties expressed
about vulnerable children, nobody in the history of hu-
manity has been as safe as a modern Western 10-year-
old). Then, apart from a ‘risk-taking’ bulge between 15
and 25, particularly in young men, there is a reasonably
straight line until around 95. This linear growth on a
logarithmic scale corresponds to an exponential growth
in annual hazard, meaning the risk of dying each year in-
creases by a fixed proportion for each year we age,
exactly the condition we seek.
We can check this observation by plotting the ratio of
hazards for adjacent years (Fig. 3), which shows that the
relative increase is fairly constant between ages 30 and
95 – this observation that dates back to Benjamin Gom-
pertz in 1825 [20]. The increase in annual hazard associ-
ated with ageing 1 year is roughly around 1.1, which is
ec in our previous notation - this means that the average
chance of dying before a next birthday increases by
around 10 % for each year of ageing, whether a man or a
Fig. 2 Annual risk of death from all causes for England and Wales,
2010–2012, known as the annual ‘hazard’ or ‘force of mortality’
Fig. 3 Between ages 30 to 100, the year-on-year increase in annual
all-cause mortality risk for England and Wales, 2010–2012
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woman and regardless of age, if over 30. Equivalently,
the average risk of dying before a next birthday doubles
roughly every 7 years. Demographers have concluded
that this ratio, 1.1, seems to be remarkably constant
across populations and over time [21].
The relationship between specific behaviours and
effective age
We now show that, given the two conditions of propor-
tional and exponentially increasing hazards, we obtain
an elegantly simple way of converting the estimated ef-
fects associated with different exposures to years of life
lost or gained.
Standard output from epidemiological studies includes
the estimated all-cause mortality hazard ratio, which is
the increased annual risk of death for those with the risk
factor compared to those without. The estimates are de-
rived from Cox regression and apply over the range of
ages being studied. The second column of Table 1 shows
some examples from recent epidemiological studies.
The crucial insight is that these hazard ratios can be eas-
ily translated into changes in effective age. Suppose r is
the hazard ratio associated with a risk factor, where r = eb
and so b is the log(hazard ratio) obtained in a Cox regres-
sion analysis. The second condition says that each in-
creased year of age is associated with a hazard ratio ec,
and so the increased risk associated with the risk factor is
equivalent to a change of t years in your effective age if
ect ¼ r ¼ eb
or equivalently
t ¼ b
c
¼ lnðrÞ
c
;
the result derived in Eq. (1). Since c ≈ ln(1.1) ≈ 0.1, we
have that t ≈ 10 ln(r). Applying this formula to the risk
factors in Table 1, and rounding to the nearest integer,
provides the values in the column headed ‘Change in
effective age’. Translating each risk factor into a change
in effective age provides a simple, but fairly rigorous,
form of communication: for example, 2 h TV a night is
associated with the same increased mortality risk as if
you were 1 year older, for any age for which this hazard
ratio holds.
There are three important caveats. Confronted with
Table 1, the immediate temptation is to start adding the
effects of the relevant exposures to get an overall num-
ber of years lost or gained. This assumes the values are
all valid simultaneously, which would be true, for ex-
ample, if all the hazard ratios had been calculated from a
single Cox regression analysis with no interactions,
However, combinations of estimates from different stud-
ies may not be too misleading provided the exposures
are clearly distinct. This means there could be a reason-
ably sound basis for the sort of ‘real-age’ calculations
shown on websites, although in practice the numbers
used may often be more guesswork than based on the
latest epidemiology.
Second, there must also be caution over any causal in-
terpretation and assumption of reversibility – we should
not casually say that changing behaviour will ‘take years’
off your age unless based on randomised evidence.
Finally, while we have argued that these two condi-
tions hold for all-cause mortality, organ-specific effective
age calculators are derived from other metrics such as
the risk of cardiovascular events in current heart age cal-
culators. These calculators assume a proportional hazard
model and so the first condition holds, and the annual
risk of cardiovascular events, while not specifically as-
sumed to be exponential, will be strongly correlated with
the risk of all-cause mortality. Thus the two conditions
should roughly hold, and so the shift in effective age
should be approximately independent of chronological
age.
As a check, raised risk factors entered into QRISK2
that raised a chronological age of 60 to a ‘QRISK
Healthy Heart Age’ of 64 were found to produce a
Table 1 Hazard ratios (r) associated with specific behaviours derived from recent epidemiological studies, translated into ‘changes in
effective age’ (t) through the formula t ≈ 10 ln(r)
Exposure/behaviour Estimated hazard ratio r Change in effective age if behaviour present (years) Reference
Smoking 20 cigarettes a day 2.20 +8 [30]
Eating 50 g processed meat a day 1.18 +2 [31]
Watching 2 h of TV a day 1.08 +1 [32]
An extra 5 units of BMI (Kg/m2) above 25. 1.29 +3 [33]
Minimal exercise (compared to inactivity) 0.82 −2 [34]
Further exercise (compared to minimal) 0.92 −1 [34]
Eating fruit and vegetables (per 2 portions a day) 0.90 −1 [35]
Taking statins (higher-risk patients) 0.91 −1 [36]
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similar difference of either 3 or 4 years when the
chronological age was varied between 30 and 80.
The impact of communicating effective age
Concepts such as effective age are clearly attractive
and even gripping metaphors: a journalist recently
listed the ‘age’ of each of their organs [22], and it is
claimed that 27,000,000 people have been provided
with their Real Age.
There is also some evidence that these ideas might
help change behaviour and improve risk factors. A re-
cent review [10] claims that vascular age is easily
understood by patients and has a greater impact on
care than presenting an estimated cardio-vascular dis-
ease risk score, citing a study [23] in which Heart
Age “was more emotionally impactful in those partici-
pants at higher actual CVD risk levels”. A trial [24]
randomised over 3000 subjects to either conventional
medical advice, a risk score or Heart Age, and found
that levels of metabolic parameters had improved sig-
nificantly after 12 months of follow-up in both risk
communication groups, but more in the group rando-
mised to receive their Heart Age. Heart age had in-
creased in the control group and decreased in the
intervention groups.
For ‘lung age’, the Step2quit study [25] found double
the quit-rates in smokers who were told their lung age
(6 % vs 14 %), and this led to recommendations [26] to
routinely use this concept. However a study [27] of 144
smokers cast doubt on the ability of lung-age to increase
motivation, while it’s been suggested that the concept
may even reduce motivation to quit for those with a
‘normal’ lung age [28].
Conclusions
Appropriate methods for communicating risk informa-
tion is a subject of intense current interest [1], but atten-
tion tends to focus on risks expressed as simple
probabilities of adverse events. Chronic risks that influ-
ence long-term outcomes are more complex. This points
to the need for randomised trials of alternative methods
of providing chronic risk information, for example in
comparison with other metaphors such as hazard ratios,
changes in life-expectancy, and time lost per exposure,
for example losing 15 min off your life expectancy for
each cigarette [29].
The idea of behaviours being associated with adding
or subtracting years from your effective age is clearly
attractive to many people, and we have shown that
these quantities can be made rigorous under plausible
assumptions. Concepts based on the idea of effective
age, such as Heart Age, are likely to become an in-
creasingly familiar part of the discourse around risk
and behaviour.
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